Reported 47,630 shares, unchanged from the prior quarter.
Reported value 74.5%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 245000 |
| 2022-03-31 | 148000 |
| 2022-06-30 | 312000 |
| 2022-09-30 | 342000 |
| 2022-12-31 | 297510 |
| 2023-03-31 | 334521 |
| 2023-06-30 | 470642 |
| 2023-09-30 | 395847 |
| 2023-12-31 | 442042 |
| 2024-03-31 | 565728 |
| 2024-06-30 | 30145825 |
| 2024-09-30 | 31042823 |
| 2024-12-31 | 24500375 |
| 2025-03-31 | 13043118 |
| 2025-06-30 | 358654 |
| 2025-09-30 | 282446 |
| 2025-12-31 | 492971 |
| 2026-03-31 | 492971 |
| 2026-06-30 | 1069303 |
| 2026-09-30 | 974111 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Reduced | 63,460 | -11,790 (-15.7%) | < 0.01% | $974,111 | 2026-11-16 | |
| Q2 2026 | Added | 75,250 | +27,620 (58.0%) | < 0.01% | $1,069,303 | 2026-08-14 | |
| Q1 2026 | Unchanged | 47,630 | 0 (0.0%) | < 0.01% | $492,971 | 2026-05-15 | |
| Q4 2025 | Unchanged | 47,630 | 0 (0.0%) | < 0.01% | $492,971 | 2026-02-17 | |
| Q3 2025 | Unchanged | 47,630 | 0 (0.0%) | < 0.01% | $282,446 | 2025-11-14 | |
| Q2 2025 | Reduced | 47,630 | -1,675,371 (-97.2%) | < 0.01% | $358,654 | 2025-08-14 | |
| Q1 2025 | Reduced | 1,723,001 | -288,524 (-14.3%) | < 0.01% | $13,043,118 | 2025-05-15 | |
| Q4 2024 | Added | 2,011,525 | +157,115 (8.5%) | < 0.01% | $24,500,375 | 2025-02-12 | |
| Q3 2024 | Added | 1,854,410 | +125,865 (7.3%) | 0.01% | $31,042,823 | 2024-11-14 | |
| Q2 2024 | Added | 1,728,545 | +1,695,345 (5106.5%) | 0.01% | $30,145,825 | 2024-08-14 | |
| Q1 2024 | Reduced | 33,200 | -10,180 (-23.5%) | < 0.01% | $565,728 | 2024-05-14 | |
| Q4 2023 | Reduced | 43,380 | -360 (-0.8%) | < 0.01% | $442,042 | 2024-02-14 | |
| Q3 2023 | Unchanged | 43,740 | 0 (0.0%) | < 0.01% | $395,847 | 2023-11-14 | |
| Q2 2023 | Added | 43,740 | +11,040 (33.8%) | < 0.01% | $470,642 | 2023-08-15 | |
| Q1 2023 | Added | 32,700 | +4,500 (16.0%) | < 0.01% | $334,521 | 2023-05-15 | |
| Q4 2022 | Added | 28,200 | +1,500 (5.6%) | < 0.01% | $297,510 | 2023-02-15 | |
| Q3 2022 | Added | 26,700 | +2,400 (9.9%) | < 0.01% | $342,000 | 2022-11-15 | |
| Q2 2022 | Added | 24,300 | +10,200 (72.3%) | < 0.01% | $312,000 | 2022-08-15 | |
| Q1 2022 | Reduced | 14,100 | -1,800 (-11.3%) | < 0.01% | $148,000 | 2022-05-13 | |
| Q4 2021 | Added | 15,900 | +2,100 (15.2%) | < 0.01% | $245,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
171 managers reported CULLINAN THERAPEUTICS INC for Q4 2025.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP | Added | 8,963,500 | +3,197,410 | 18.78% | $92,772,225 | 7 qtrs |
| BIOIMPACT CAPITAL LLC | Unchanged | 7,648,268 | 0 | 9.06% | $79,159,574 | 20 qtrs |
| BVF INC IL | Unchanged | 5,750,683 | 0 | 2.0% | $59,519,569 | 20 qtrs |
| BlackRock Inc | Added | 4,400,296 | +230,334 | < 0.01% | $45,543,064 | 6 qtrs |
| VANGUARD GROUP INC | Added | 3,298,504 | +355,179 | < 0.01% | $34,139,516 | 20 qtrs |
| Kynam Capital Management LP | Added | 3,114,132 | +811,960 | 2.06% | $32,231,266 | 5 qtrs |
| Blue Owl Capital Holdings LP | Reduced | 2,350,972 | -160,000 | 7.51% | $24,332,560 | 9 qtrs |
| STATE STREET CORPORATION | Added | 2,197,338 | +520,024 | < 0.01% | $22,742,448 | 20 qtrs |
| Affinity Asset Advisors LLC | Added | 1,932,106 | +1,668,289 | 1.14% | $19,997,297 | 9 qtrs |
| RTW INVESTMENTS LP | Unchanged | 1,705,960 | 0 | 0.18% | $17,656,686 | 7 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2025
- Filed
- February 17, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 47,630
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.